Before a drug is available in pharmacies, it undergoes numerous regulated processes. GMP inspections ensure that quality, safety and efficacy are guaranteed at all times. This article highlights the key steps along the manufacturing chain and explains the role inspections play in this process.

Development and manufacture in accordance with GMP requirements

The manufacture of a medicinal product begins long before actual production, with the development of the active ingredient. Even at this early stage, Good Manufacturing Practice (GMP) requirements come into play to systematically ensure subsequent quality, drug safety and efficacy. Manufacturing processes are described in detail, validated and continuously monitored so that they are reproducible at all times and deliver consistent results. Qualified equipment and strictly controlled environmental conditions, which are regularly checked as part of GMP inspections, play a central role in this. The documentation of all process steps is also essential, as it forms the basis for transparency and traceability.

Quality assurance and qualification at the heart of inspections

Further down the line, quality assurance is a crucial component throughout the entire manufacturing chain. Terms such as qualification and validation are of central importance here and are closely interlinked. During GMP inspections, inspectors check whether all processes comply with regulatory requirements and whether an effective quality management system has been implemented. This also involves assessing how deviations are recorded, documented and addressed. Companies must ensure that corrective and preventive actions (CAPA) are effectively implemented to guarantee long-term compliance. Comprehensive GMP documentation helps to demonstrate compliance with all requirements at all times.

Role of authorities and conduct of GMP inspections

GMP inspections are carried out by the competent authorities to verify compliance with legal requirements in pharmaceutical manufacturing. Depending on the country, the responsible bodies may include, for example, the FDA, the EMA or the Russian SID&GP. Manufacturing sites are audited at regular intervals, with both announced and unannounced inspections taking place. The inspection includes, amongst other things, the review of documentation, staff qualifications, and production and control processes. Particular attention is paid to compliance with validated procedures and the proper execution of all quality-related activities. The aim is to ensure that every medicinal product is manufactured under strictly controlled conditions and that potential risks to patients are consistently minimised.

Release, Distribution and Monitoring

Following successful manufacture, the medicinal product is released by the qualified person, who confirms that all GMP requirements have been met. Only then may the product enter the supply chain and be delivered to pharmacies.

Distribution is also subject to strict regulatory requirements to ensure the quality and integrity of the medicinal product during transport and storage. Temperature controls, suitable packaging and documented supply chains play a key role in this. Furthermore, continuous monitoring and periodic GMP inspections ensure that quality is maintained throughout the entire lifecycle and complies with applicable standards at all times.

Ultimately, it is clear that GMP inspections are an indispensable part of the pharmaceutical industry. They build confidence in drug safety. We are happy to support your company with experienced pharmaceutical interpreters and high-quality pharmaceutical translations, ensuring your product reaches pharmacies smoothly.

Image: Jahanzeb Ahsan, unsplash.com